Biogen Inc BIIB:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/25/21 EST
277.26quote price arrow down-5.48 (-1.94%)
Volume
972,909
52 week range
223.25 - 363.92

...

Loading . . .

KEY STATS

  • Open284.26
  • Day High284.40
  • Day Low274.71
  • Prev Close277.26
  • 52 Week High363.92
  • 52 Week High Date11/04/20
  • 52 Week Low223.25
  • 52 Week Low Date11/09/20
  • Market Cap42.238B
  • Shares Out152.34M
  • 10 Day Average Volume1.16M
  • Dividend-
  • Dividend Yield-
  • Beta0.44
  • 1 Year % Change-14.45

RATIOS/PROFITABILITY

  • EPS (TTM)24.45
  • P/E (TTM)11.34
  • Fwd P/E (NTM)14.40
  • EBITDA (MRQ)5.46B
  • ROE (MRQ)33.28%
  • Revenue (MRQ)13.445B
  • Gross Margin (MRQ)86.57%
  • Net Margin (MRQ)30.16%
  • Debt To Equity (MRQ)69.40%

EVENTS

  • Earnings Date04/20/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest BIIB News From Our Partners

QUOTE FINDER

Profile

MORE
Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration...
Stelios Papadopoulos Ph.D.
Chairman
Michel Vounatsos
Chief Executive Officer
Michael McDonnell
Chief Financial Officer
Robin Kramer
Chief Accounting Officer
Susan Alexander Esq.
Executive Vice President
Address
225 Binney St
Cambridge, MA
02142-1031
United States